FDA Clearance Tracker · P130022-S050
Senza Spinal Cord Stimulation (SCS) Systems
Last checked: Nov 20, 2026Latest source record: Nov 1, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Nov 1, 2024
Approved
Time to decision
536 days
Received May 15, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P130022-S050
- Device name
- Senza Spinal Cord Stimulation (SCS) Systems
- Applicant
- Nevro Corporation
- Applicant location
- Redwood City, CA
- Received
- May 15, 2023
- Decided
- Nov 1, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P130022
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for a modification of a warning in the device labeling (i.e., Physician Implant Manual, Patient Manual, Information for Prescribers, and Clinician Programmer Manual) to state that frequencies between 1.2 kHz and 10 kHz may be used to provide paresthesia-free stimulation when the system (i.e., amplitude, pulse width) is configured to deliver paresthesia-free stimulation.
Source documents
Other decisions for Nevro Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Senza Spinal Cord Stimulation (SCS) SystemPMA supplement
P130022-S042 · Decided Jan 18, 2022 · 180 days after receipt · Panel Track
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.